Spina Bifida treatment in Turkey: Surgery, Fetal Repair & Costs

What is spina bifida and what causes it?

Spina bifida emerges early. Very early, in fact, within the first month of pregnancy, often before a woman even recognizes she is pregnant. The neural tube, which eventually becomes the brain and spinal cord, fails to seal properly between weeks 3 and 4 of development, leaving portions of the spine exposed or malformed as a result.

Globally, it ranks among the most prevalent serious birth defects. Research from the US Centers for Disease Control indicates approximately 1,500 affected infants are born annually in the United States. Meanwhile, EUROCAT surveillance documents a prevalence spanning 3 to 4 cases per 10,000 births throughout Europe, though regional figures vary considerably, ranging from low incidence in some Scandinavian countries to higher rates in parts of Central Europe.

The underlying mechanisms combine genetic predisposition with environmental triggers, though scientists continue to unravel the precise interactions. Among modifiable risk factors, inadequate folic acid intake stands out as the most preventable cause. This B vitamin plays a foundational role in neural tube closure. Healthcare providers universally advise women planning conception to take 400–800 micrograms of folic acid daily, a simple measure that substantially reduces occurrence risk.

What are the different types of spina bifida?

The spectrum of spina bifida encompasses distinct presentations, each carrying different implications for long-term function and medical requirements:

Risk factors

Neural tube development depends on multiple variables. Researchers have identified several modifiable and non-modifiable factors that heighten susceptibility, though the complete picture remains incompletely understood.

• Genetic and ethnic influences: Family members with neural tube defects carry elevated risk. Hispanic and Caucasian ancestry correlates with higher incidence rates in epidemiological studies.
• Nutritional status: Folate insufficiency during the periconception window represents the single most preventable cause. This micronutrient directs neural tissue formation in the earliest embryonic stages.
• Medication exposure: Anticonvulsants, particularly valproate used for seizure control, substantially increase risk when administered during the first trimester.
• Maternal metabolic and physiological factors: Poorly controlled gestational diabetes, maternal obesity (BMI > 30),and elevated core body temperature in early pregnancy have all been associated with increased occurrence.

Risk reduction hinges on adequate folate supplementation before conception and routine prenatal medical oversight.

What are the symptoms of spina bifida and how is it diagnosed?

Presentation varies significantly based on lesion type and anatomical extent. Detection may occur before delivery, at birth, or later during childhood development.

Prenatal detection

The majority of open myelomeningoceles surface during standard ultrasound imaging performed between 18 and 20 weeks gestation.

Characteristic sonographic findings include:

• The "banana sign", abnormal cerebellum curvature
• The "lemon sign", inward buckling of frontal bone margins

These indirect markers reflect Chiari II malformation, a frequent accompaniment of open myelomeningocele.

Complementary diagnostic modalities:

• Maternal serum alpha-fetoprotein (AFP): Characteristically elevated when neural tissue is exposed.
• High-resolution fetal MRI: Supplies detailed anatomical assessment of the spinal lesion and intracranial structures.

Signs visible at delivery or after birth

Open lesions announce themselves unmistakably:

• Protruding sac on the lower back, the defining hallmark of open myelomeningocele
• Weakness below the lesion level, ranging from mild reduction in strength to total loss of motor function
• Loss of bladder and bowel control, present in nearly all myelomeningocele cases due to nerve involvement
• Hydrocephalus: cerebrospinal fluid accumulation occurs in 70 to 90 percent of patients
• Chiari II malformation, brainstem displacement present in the majority of severe cases

Occulta: typically silent

Most individuals remain entirely asymptomatic. The condition is frequently stumbled upon incidentally during spinal imaging performed for unrelated reasons. A minority develop tethered cord, a condition where neural tissue becomes abnormally adhered, leading to symptoms that appear during later childhood: back pain, leg weakness, or changes in bladder function.

Spina Bifida treatment options in Turkey

Spina bifida management extends far beyond any single operation. It represents a coordinated, evolving care pathway spanning from birth through adulthood, with interventions adjusted as the child develops and circumstances change.

Turkish neuroscience centers accredited under international standards bring together fetal surgeons, pediatric neurosurgeons, pediatric urologists, orthopedic specialists, and rehabilitation medicine experts into unified teams.

Fetal surgical repair (in utero closure)

Recent decades have witnessed a paradigm shift: prenatal surgical intervention now offers the possibility of closing myelomeningocele defects before birth, typically between 19 and 26 weeks of gestation. The landmark MOMS Trial demonstrated substantial benefits, shunt dependency dropped from 82% to approximately 40%, motor outcomes improved measurably at 2.5 years, and hindbrain herniation rates decreased notably. Yet fetal surgery demands highly specialized infrastructure and carries inherent maternal and fetal risks, including preterm labor.

Neonatal closure (postnatal repair)

When fetal intervention is unavailable or contraindicated, repair occurs urgently within 24 to 72 hours post-delivery. This procedure seals the open spinal sac, shields exposed nervous tissue, and prevents life-threatening bacterial meningitis. Earlier closure generally correlates with superior neurological preservation; speed matters critically.

Shunt placement for excess brain fluid

Ventriculoperitoneal shunting becomes necessary when hydrocephalus develops, affecting 70 to 90 percent of myelomeningocele cases. The device diverts cerebrospinal fluid away from brain ventricles into the abdominal cavity. An alternative technique, endoscopic third ventriculostomy, bypasses implantation altogether in suitable anatomical contexts, eliminating long-term foreign body concerns.

Release of tethered spinal cord

Growing children sometimes experience cord entrapment at the original repair site. This tethered cord can trigger progressive weakness, pain, or loss of function. Pediatric neurosurgeons perform delicate release procedures to prevent or reverse neurological decline as the spine lengthens during development.

Bladder and bowel management

Neurogenic bladder demands lifelong oversight; neglect causes permanent kidney scarring. Clean intermittent catheterization initiated from birth remains the foundational approach. Reconstructive urological procedures, bladder expansion, continent catheterizable pouches, emerge as adolescents mature and develop continence goals.

Orthopedic and physical rehabilitation

Children with myelomeningocele thrive through coordinated physiotherapy optimizing motor abilities, orthotic supports (braces, adaptive devices) enabling safer mobility, and surgical correction of structural deformities, hip displacement, spinal curvature, clubfoot. Intensive rehabilitation beginning in infancy dramatically enhances functional independence throughout life.

Each child's pathway differs. The clinics partnered with Turquie Santé tailor comprehensive care strategies to individual medical profiles and family circumstances. Consulting with an experienced pediatric neurosurgeon and multidisciplinary team ensures your child receives evidence-based, personalized planning.

Turquie Santé connects families with accredited specialists who design treatment plans reflecting your child's unique needs. Contact us to begin exploring therapeutic options suited to your situation.